Synthesis and anticonvulsant properties of tetrahydroisoquinoline derivatives

Farmaco

Volumn 59, Issue 1, 2004, Pages 7-12

  Gitto, Rosaria ^a   Caruso, Roberta ^a   Orlando, Valerie ^a   Quartarone, Silvana ^a   Barreca, Maria Letizia ^a   Ferreri, Guido ^b   Russo, Emilio ^b   De Sarro, Giovambattista ^b   Chimirri, Alba ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

AMPA receptor antagonists; Anticonvulsant agents; DBA 2 mice; Tetrahydroisoquinolines

Indexed keywords

1 (2,3 DIFLUOROPHENYL) 6,7 DIMETHOXY 1,2,3,4 TETRAHYDROISOQUINOLINE; 1 (3 AMINOPHENYL) 6,7 DIMETHOXY 1,2,3,4, TETRAHYDROISOQUINOLINE; 1 (3,4 DIFLUOROPHENYL) 6,7 DIMETHOXY 1,2,3,4 TETRAHYDROISOQUINOLINE; 1 (3,5 DICHLOROPHENYL) 6,7 DIMETHOXY 1,2,3,4 TETRAHYDROISOQUINOLINE; 2 ACETYL (2,3 DICHLOROPHENYL) 6,7 DIMETHOXY 1,2,3,4 TETRAHYDROISOQUINOLINE; 2 ACETYL (2,3 DIFLUOROPHENYL) 6,7 DIMETHOXY 1,2,3,4 TETRAHYDROISOQUINOLINE; 2 ACETYL (3 CHLOROPHENYL) 6,7 DIMETHOXY 1,2,3,4 TETRAHYDROISOQUINOLINE; 2 ACETYL (3,4 DICHLOROPHENYL) 6,7 DIMETHOXY 1,2,3,4 TETRAHYDROISOQUINOLINE; 2 ACETYL (3,4 DIFLUOROPHENYL) 6,7 DIMETHOXY 1,2,3,4 TETRAHYDROISOQUINOLINE; 2 ACETYL (3,5 DICHLOROPHENYL) 6,7 DIMETHOXY 1,2,3,4 TETRAHYDROISOQUINOLINE; 2 ACETYL 1 (3 AMINOPHENYL) 6,7 DIMETHOXY 1,2,3,4 TETRAHYDROISOQUINOLINE; 2 ACETYL 6,7 DIMETHOXY 1 (3 NITROPHENYL) 1,2,3,4 TETRAHYDROISOQUINOLINE; TETRAHYDROISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; FOLLOW UP; MOLECULAR MODEL; MOUSE; NONHUMAN; SEIZURE; STRUCTURE ACTIVITY RELATION;

EID: 1642498133     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2003.10.003     Document Type: Article

References (31)

1. Doble A. Excitatory amino acid receptors and neurodegeneration. Therapie. 50:1995;319-337.
2. Muir K.W., Lees K.R. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 26:1995;503-513.
3. McEntee W.C., Crook T.H. Glutamate, its role in learning, memory, and the aging brain. Psychopharmacology. 111:1993;391-401.
4. Dingledine R., Borges K., Bowie D., Traynelis S.R. The glutamate receptor ion channels. Pharmacol. Rev. 51:1999;7-61.
5. Lees G.J. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders. Drugs. 59:2000;33-78.
6. Lin Z., Kadaba P.K. Molecular targets for the rational design of antiepileptic drugs and related neuroprotective agents. Med. Res. Rev. 17:1997;537-572.
7. Rogawski M.A., Donevan S.D. AMPA receptors in epilepsy and as targets for antiepileptic drugs. Adv. Neurol. 79:1999;947-963.
8. Chimirri A., Gitto R., Zappalà M. AMPA receptor antagonists. Exp. Opin. Ther. Pat. 9:1999;557-570.
9. Chapman A.G., Al-Zubaidy Z., Meldrum B.S. Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice. Eur. J. Pharmacol. 231:1993;301-303.
10. Donevan S.D., Rogawski M.A. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron. 10:1993;51-59.
11. Rogawski M.A. Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trend. Pharmacol. Sci. 14:1993;325-331.
12. Solyom S., Tarnawa I. Non-competitive AMPA antagonists of 2,3-benzodiazepine type. Curr. Pharm. Des. 8:2002;913-939.
13. Andrási F. Talampanel. Drug. Future. 26:2001;754-756.
14. De Sarro G., Chimirri A., De Sarro A., Gitto R., Grasso S., Giusti P., et al. GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 Mice. Eur. J. Pharmacol. 294:1995;411-422.
15. Chimirri A., De Sarro G., De Sarro A., Gitto R., Grasso S., Quartarone S., et al. 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists. J. Med. Chem. 40:1997;1258-1269.
16. De Sarro G., Rizzo M., Sinopoli V.A., Gitto R., De Sarro A., Zappalà M., et al. Relationship between anticonvulsant activity and plasma level of some 2,3-benzodiazepines in genetically epilepsy prone rats. Pharmacol. Biochem. Behav. 61:1998;215-220.
17. De Sarro G., Rizzo M., Spagnolo C., Gitto R., De Sarro A., Scotto G., et al. Anticonvulsant activity and plasma level of some 2,3-benzodiazepin-4-ones (CFMs) in genetically epilepsy prone rats. Pharmacol. Biochem. Behav. 63:1999;621-627.
18. Chimirri A., De Sarro G., De Sarro A., Gitto R., Quartarone S., Zappalà M., et al. 3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists. J. Med. Chem. 41:1998;3409-3416.
19. Gitto R., Zappalà M., De Sarro G., Chimirri A. Design and development of 2,3-benzodiazepine (CFM) noncompetitive AMPA receptor antagonists. Il Farmaco. 57:2002;129-134.
20. De Sarro G., Ferreri G., Gareri P., Russo E., De Sarro A., Gitto R., et al. Comparative anticonvulsant activity of some 2,3-benzodiazepines in rodents. Pharmacol. Biochem. Behav. 74:2003;595-602.
21. Chimirri A., Bevacqua F., Gitto R., Quartarone S., Zappalà M., De Sarro A., et al. Synthesis and anticonvulsant activity of new 11H-triazolo[4,5-c][2,3]benzodiazepines. Med. Chem. Res. 9:1999;203-212.
22. Zappalà M., Gitto R., Bevacqua F., Quartarone S., Chimirri A., Rizzo M., et al. Synthesis and evaluation of pharmacological and pharmacokinetic properties of 11H-[1,2,4]triazolo[4,5-c][2,3]benzodiazepin-3(2H) -ones. J. Med. Chem. 43:2000;4834-4839.
23. Gitto R., Orlando V., Quartarone S., De Sarro G., De Sarro A., Russo E., et al. Synthesis and evaluation of pharmacological properties of novel annelated 2,3-benzodiazepine derivatives. J. Med. Chem. 46:2003;. (web release July 10, 2003).
24. Chimirri A., Gitto R., Quartarone S., Orlando V., De Sarro A., De Sarro G. Synthesis and pharmacological properties of new 3-ethoxycarbonyl-11H-[1,2,4] triazolo[4,5-c][2,3]benzodiazepines. Il Farmaco. 57:2002;759-763.
25. Barreca M.L., Gitto R., Quartarone S., De Luca L., De Sarro G., Chimirri A. Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists. J. Chem. Inf. Comp. Sci. 43:2003;651-655.
26. Gitto R., Barreca M.L., De Luca L., De Sarro G., Ferreri G., Quartarone S., et al. Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist. J. Med. Chem. 46:2003;197-200.
27. Viel C., Dorme R., Rumpf P. Synthesis and properties of new 6,7-dimethoxy-3,4-dihydro and 1,2,3,4-tetrahydroisoquinolines. II. 1-Phenyl- and 1-benzyl- derivatives. Bull. Soc. Chim. Fr. 6:1966;1956-1966.
28. Yokoyama A., Ohwada T., Shudo K. Prototype Pictet-Spengler reactions catalyzed by superacids. Involvement of dicationic superelectrophiles. J. Org. Chem. 64:1999;611-617.
29. Collins R.L. Audiogenic seizures. Purpura P., Penry J.K., Tower D., Woodbury D.M., Walter R. Experimental Models of Epilepsy. 1972;347-372 Raven Press, New York.
30. De Sarro G.B., Croucher M.J., Meldrum B.S. Anticonvulsant actions of DS 103-282: pharmacological studies in rodents and the baboon papio papio. Neuropharmacology. 23:1984;526-530.
31. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effects experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.